[Federal Register Volume 83, Number 213 (Friday, November 2, 2018)]
[Notices]
[Pages 55171-55172]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-23976]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Board of Scientific
Counselors, National Center for Injury Prevention and Control, (BSC,
NCIPC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Board of Scientific Counselors,
National Center for Injury Prevention and Control, (BSC, NCIPC). This
meeting is open to the public limited only by the space and ports
available. The meeting room accommodates 70 participants and there will
be 75 ports available. Due to the limited availability of phone line
ports, we are encouraging the pubic to please register using the link
provided: Register Here. There will be a public comment period at the
end of the day from 03:30 p.m.--04:00 p.m.
DATES: The meeting will be held on December 12, 2018, 09:00 a.m. to
04:30 p.m., EST.
ADDRESSES: Center for Disease Control and Prevention, Chamblee Campus,
Building 106, Conference Room 1-A, 4770 Buford Highway, Atlanta,
Georgia 30341 and via Teleconference: Dial-In Number: 1-888-780-9652,
Participant Code: 8435823.
FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770
Buford Highway, NE, Mailstop F-63, Atlanta, GA 30341, Telephone (770)
488-1430. Email address: [email protected]
SUPPLEMENTARY INFORMATION:
Purpose: The Board will: (1) Conduct, encourage, cooperate with,
and assist other appropriate public health authorities, scientific
institutions, and scientists in the conduct of research,
investigations, experiments, demonstrations, and studies relating to
[[Page 55172]]
the causes, diagnosis, treatment, control, and prevention of physical
and mental diseases, and other impairments; (2) assist States and their
political subdivisions in preventing and suppressing communicable and
non-communicable diseases and other preventable conditions and in
promoting health and well-being; and (3) conduct and assist in research
and control activities related to injury. The Board of Scientific
Counselors makes recommendations regarding policies, strategies,
objectives, and priorities; and reviews progress toward injury
prevention goals and provides evidence in injury prevention-related
research and programs. The Board also provides advice on the
appropriate balance of intramural and extramural research, the
structure, progress and performance of intramural programs. The Board
is designed to provide guidance on extramural scientific program
matters, including the: (1) Review of extramural research concepts for
funding opportunity announcements; (2) conduct of Secondary Peer Review
of extramural research grants, cooperative agreements, and contracts
applications received in response to the funding opportunity
announcements as it relates to the Center's programmatic balance and
mission; (3) submission of secondary review recommendations to the
Center Director of applications to be considered for funding support;
(4) review of research portfolios, and (5) review of program proposals.
Matters to be Considered: The Board of Scientific Counselors will
discuss science matters to include research strategies needed to guide
the Center's focus on reducing opioid overdose and to review the
recommendations from the opioid prescribing for acute and chronic pain
workgroup. Agenda items are subject to change as priorities dictate.
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2018-23976 Filed 11-1-18; 8:45 am]
BILLING CODE 4163-19-P